Inventaire - your friends and communities are your best library

bHLH-PAS proteins in cancer

author

Daniel J. Peet

Adrienne E Sullivan

published in: Nature Reviews Cancer

date of publication: 2013-12-01

language: English

Cites articles 181

Date

Title

Authors

2013-03-15

Regulating the ARNT/TACC3 Axis: Multiple Approaches to Manipulating Protein/Protein Interactions with Small Molecules

Kevin H. Gardner, Heiko Wurdak
2013-03-29

Cancer genome landscapes

Bert Vogelstein, Kenneth W Kinzler, Victor Velculescu, Luis Alberto Diaz Jr, Nickolas Papadopoulos, Shibin Zhou
2013-03-01

ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice

Kazuhiro Shiizaki
2013-07-08

Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

Oihana Murillo
2013-04-30

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

Ivana Sestak, Mitch Dowsett, Andrea LaCroix, Umberto Veronesi, Jack Cuzick
2013-04-17

Reciprocal regulation of the basic helix-loop-helix/Per-Arnt-Sim partner proteins, Arnt and Arnt2, during neuronal differentiation

Nan Hao, Daniel J. Peet
2013-03-01

Influence of metabolism on epigenetics and disease

William G. Kaelin
2013-04-01

What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer

William G. Kaelin
2013-04

Allosteric inhibition of hypoxia inducible factor-2 with small molecules
2013-07-09

A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells

Graham Packham, Ali Tavassoli
2013-07-08

Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy

Yi-Cheng Chang, Yung-Ming Jeng
2013-04-04

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

Christopher E. Barbieri, Francesca Demichelis, Mark Rubin, Bert W. O'Malley, Mirjam Blattner, Pengbo Zhou
2013-02-01

Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm

Vivek Kumar, Joseph Takahashi, Zhijian J Chen
2013-06-01

SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging
2012-05-31

Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex

Joseph Takahashi
2012-08-30

Xenobiotics and loss of cell adhesion drive distinct transcriptional outcomes by aryl hydrocarbon receptor signaling

Nan Hao, Kian Leong Lee, Sebastian Furness
2012-03-28

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Gad Getz, Jordi Barretina Ginesta, Kristin Ardlie, Jill P. Mesirov, Stacey Gabriel, Levi A Garraway
2012-02-03

Hypoxia-inducible factors in physiology and medicine
2012-05-06

An oxygen-regulated switch in the protein synthesis machinery
2012-02-15

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation

Christopher G Duncan, , Ryan E Looper
2012-08-27

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Anjana Rao
2012-08-01

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

Anne Brüstle, Guido Reifenberger, Andrew Wakeham, Tak W Mak, Joshua Munger
2012-02-13

Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function

Sven Hennig
2012-11-01

Circadian topology of metabolism
2012-09-28

The NAD metabolome--a key determinant of cancer cell biology
2012-07-02

Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis

Vivek Kumar, Joseph Takahashi
2012-11-16

Small molecule modifiers of circadian clocks

Joseph Takahashi
2012-03-29

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

Joseph Takahashi, Thomas Burris
2012-07-12

Identification of small molecule activators of cryptochrome

Francis J. Doyle III, Tsuyoshi Hirota, David A. Brenner, Peter G. Schultz
2012-06

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Eric Lander, Candace Guiducci, Kristian Cibulskis, Gad Getz, Daniel Auclair, Wendy Winckler, Gordon Saksena, Nicolas Stransky, Douglas Voet, Kristin Ardlie, Elizabeth Nickerson, Jean-Philippe Theurillat, Petar Stojanov, Gunther Boysen, Eliezer Van Allen, Christopher E. Barbieri, Francesca Demichelis, Mark Rubin, Philip W. Kantoff, Matthew Meyerson, Stacey Gabriel, Levi A Garraway, Todd Golub, Andrey Sivachenko, Sung-Suk Chae, Sylvan C Baca, Mirjam Blattner, Robert Onofrio, Naoki Kitabayashi, Terry Vuong, Scott L Carter, Wasay M Hussain, Ashutosh Tewari, Juan Miguel Mosquera, Colm Morrissey, Holger Moch, Michelle Redman-MacLaren, Alex H Ramos
2012-05-03

A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer

Vincent W. Keng, Loris Mularoni, Jef D Boeke, Bert W. O'Malley, Michael S. Torbenson, David A Largaespada, Kevin A. T. Silverstein
2012-04-18

Sim2 prevents entry into the myogenic program by repressing MyoD transcription during limb embryonic myogenesis

Emmanuelle Havis, Marie-Ange Bonnin, Frédéric Relaix, Delphine Duprez

Article - wd:Q38164994

Welcome to Inventaire

the library of your friends and communities

learn more